HDFC MF and ADIA Lead Major ₹777 Crore Block Deal in Corona Remedies
A massive liquidity event unfolded in the pharmaceutical sector as Sepia Investments and Anchor Partners offloaded significant stakes in Corona Remedies Limited. This high-value block deal attracted a heavy-weight lineup of domestic and international institutional investors, signaling strong confidence in the company's long-term prospects.
Breakdown of the Mega Divestment
On June 17, 2026, the stock exchange witnessed a substantial transfer of ownership in Corona Remedies. The primary seller, Sepia Investments, divested 43,28,943 shares at a price of ₹1,730 per share, amounting to approximately ₹748.9 crore.
Adding to this exit, Anchor Partners also offloaded 1,61,861 shares at the same price point of ₹1,730, contributing an additional ₹28 crore to the transaction. In total, these two sellers collectively exited positions worth roughly ₹776.9 crore in the pharmaceutical major.
HDFC Mutual Fund Dominates the Buy Side
The transaction saw participation from twelve distinct institutional buyers, with HDFC Mutual Fund emerging as the most aggressive acquirer. By purchasing 24,50,000 shares, HDFC MF invested approximately ₹423.9 crore, effectively absorbing more than half of the total deal value.
The buy-side appetite was further bolstered by several other major players:
- Aditya Birla Sun Life Mutual Fund: Acquired 4,90,000 shares worth ₹84.8 crore.
- Aberdeen Asian Smaller Companies Investment Trust Plc: Bought 4,50,868 shares for roughly ₹78 crore.
- Invesco Mutual Fund: Picked up 2,89,017 shares valued at ₹50 crore.
- Aberdeen Standard Sicav I: Acquired 2,74,132 shares worth ₹47.4 crore.
Global Institutional Interest in Corona Remedies
Beyond domestic mutual funds, the deal highlighted significant interest from global sovereign wealth and international asset management firms. The Abu Dhabi Investment Authority (ADIA) participated in the deal, acquiring 39,130 shares worth approximately ₹6.8 crore.
Peserta internasional terkemuka lainnya termasuk WhiteOak Capital Mutual Fund, yang menginvestasikan ₹25,1 crore, dan India Acorn ICAV - Ashoka WhiteOak Emerging Markets Equity Fund, yang menghabiskan ₹25,7 crore. Kesepakatan ini juga melibatkan partisipasi yang lebih kecil dari Kotak Mahindra Mutual Fund (₹28 crore), Factory Mutual Insurance Company (₹1,9 crore), dan TCW White Oak Emerging Markets Equity Fund (₹33 lakh), yang menunjukkan konsensus institusional yang luas terhadap valuasi saham tersebut.
Poin-Poin Penting
- Peristiwa Likuiditas Masif: Total divestasi oleh Sepia Investments dan Anchor Partners mencapai sekitar ₹776,9 crore pada harga ₹1.730 per saham.
- Posisi Dominan HDFC MF: HDFC Mutual Fund merupakan pembeli utama, yang menyumbang lebih dari 50% dari nilai kesepakatan dengan investasi sebesar ₹423,9 crore.
- Basis Investor yang Beragam: Kesepakatan ini melibatkan perpaduan yang sehat antara reksa dana domestik India dan raksasa global seperti ADIA dan Aberdeen, yang menunjukkan kepercayaan institusional yang kuat terhadap Corona Remedies.